| 663 |
Centers for Disease Control and Prevention |
Html |
en |
Bidis and Kreteks - Smoking & Tobacco Use |
Tobacco Industry and Products Fact Sheets. |
| Mortality Weekly Report | 0.736921 |
| reduced oxygen absorption | 0.46092 |
| nicotine addiction | 0.411423 |
| Tobacco Control Act | 0.611152 |
| conventional cigarettes | 0.418918 |
| lung cancer | 0.437099 |
| Disease Control | 0.52913 |
| oral cancer | 0.475271 |
| Yusuf S. Risk | 0.466429 |
| World Health Organization | 0.621106 |
| Clove Cigarette Smoking | 0.537694 |
| Occupational Lung Diseases | 0.462932 |
| Risk Factors | 0.459423 |
| High School Students—United | 0.725188 |
| carbon monoxide | 0.489706 |
| bidi smoking | 0.968962 |
| Bidi Cigarettes | 0.670044 |
| long-term health effects | 0.643066 |
| Nov | 0.624469 |
| Southeast Asian countries | 0.48994 |
| International Journal | 0.447961 |
| combustible tobacco product | 0.517574 |
| Family Smoking Prevention | 0.536764 |
| U.S. middle school | 0.485032 |
|
| Fukui T. Bidi | 0.800783 |
| acute lung injury | 0.49234 |
| S. Bidi Smoking | 0.684593 |
| Bidi Cigarette | 0.568238 |
| United States.1,3,5,6 | 0.410967 |
| hand-rolled cigarettes | 0.426767 |
| flavored cigarettes | 0.412101 |
| Regular kretek smokers | 0.474755 |
| School Students—United States | 0.723091 |
| Tobacco Research. | 0.423906 |
| Carbon Monoxide Yields | 0.459948 |
| high school students | 0.481784 |
| kretek smoking | 0.511201 |
| middle school males | 0.485466 |
| lung problems | 0.415878 |
| T. Bidi Smoking | 0.835199 |
| bidis | 0.515884 |
| relative standard error | 0.459828 |
| stomach cancer | 0.412786 |
| low prevalence | 0.490352 |
| research studies | 0.48493 |
| coronary heart disease | 0.477084 |
| adverse health conditions | 0.496028 |
| abnormal lung function | 0.489677 |
|
CLICK HERE |
| 992 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: A Cluster of LymphocyticChoriomeningitis Virus Infections Transmitted Through OrganTransplantation - Iowa, 2013 |
Ilana J. Schafer, DVM1, Rachel Miller, MD2, Ute Ströher, PhD3, Barbara Knust, DVM3, Stuart T. Nichol, PhD3, Pierre E. |
| CDC | 0.757274 |
| mental status | 0.719175 |
| mild memory deficits | 0.814435 |
| public health practitioners | 0.795062 |
| Human Services | 0.785501 |
| immunoglobulin M. Patient | 0.859371 |
| MMWR HTML versions | 0.793484 |
| U.S. Department | 0.782906 |
| rodent exposure | 0.819648 |
| Organ Sharing | 0.816741 |
| organ transplantation | 0.89541 |
| oral ribavirin | 0.881817 |
| electronic PDF version | 0.795955 |
| prompt treatment initiation | 0.798038 |
| lymphocytic choriomeningitis virus | 0.832608 |
| LCMV-infected organ recipients | 0.933902 |
| large intracerebral hemorrhage | 0.844404 |
| early posttransplant period | 0.796513 |
| allograft failure | 0.712583 |
| Contact GPO | 0.719617 |
| organ transplant recipients | 0.989377 |
| transcription–polymerase chain reaction | 0.810411 |
| nontransplanted donor organs | 0.844486 |
| LCMV infections | 0.821141 |
|
| respiratory compromise | 0.716239 |
| original paper copy | 0.788648 |
| causative agent | 0.719132 |
| previous cornea recipients | 0.867208 |
| right kidney | 0.716729 |
| Diagnostic testing | 0.719774 |
| ill recipients | 0.856017 |
| original MMWR paper | 0.8013 |
| U.S. Government Printing | 0.796838 |
| blood samples | 0.716659 |
| aortic endothelial cells | 0.813912 |
| multiple recipients | 0.763598 |
| influenza-like illness | 0.722587 |
| critical condition | 0.718147 |
| United Network | 0.729508 |
| intravenous ribavirin treatment | 0.916692 |
| common organ donor | 0.968628 |
| life-threatening disease | 0.726203 |
| intravenous immunoglobulin | 0.744662 |
| rodent-borne virus | 0.721405 |
| organ donors | 0.777923 |
| organ transplant-associated cluster | 0.882185 |
| occasional aseptic meningitis | 0.834182 |
| intracranial hemorrhage | 0.725978 |
|
CLICK HERE |
| 5752 |
Centers for Disease Control and Prevention |
Html |
en |
Methyl formate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 8038 |
Centers for Disease Control and Prevention |
Html |
en |
Kenya - Blog: Improving Indoor Air Quality in Rural Kenya - CDC Global Health |
In Kenya, the CDC is addressing the region's toughest health problems at their source, directly working with vulnerable families and communities in local hospitals, clinics, and laboratories. |
| clean-burning cookstoves | 0.86462 |
| indoor air quality | 0.819837 |
| personal air pollution | 0.827416 |
| U.S. CDC Kenya | 0.895292 |
| traditional cookstoves | 0.829792 |
| high acceptability | 0.720187 |
| Clean Cookstoves | 0.974862 |
| viable commercial market | 0.838458 |
| health impact | 0.728284 |
| Disease Control | 0.83266 |
| health benefits—CDC | 0.73921 |
| common respiratory diseases | 0.807423 |
| Air Monitoring Group | 0.82705 |
| climate change | 0.722952 |
| household air quality | 0.819508 |
| World Health Organization | 0.812219 |
| rural western Kenya | 0.858958 |
| local economies | 0.72077 |
| Kenya Medical Research | 0.847225 |
| cooking fuel | 0.720293 |
| people worldwide die | 0.789487 |
| cleaner cookstove alternatives | 0.824639 |
| short term effects | 0.808049 |
| kitchen performance tests | 0.807173 |
| ‘quick stove | 0.742085 |
|
| acute respiratory infections | 0.80335 |
| clay foundation | 0.719457 |
| efficient cookstoves | 0.878004 |
| Secretary Clinton | 0.721138 |
| health toll staggering | 0.814739 |
| indoor air pollution | 0.83372 |
| ceramic cylinder | 0.717271 |
| rural Kenya | 0.752993 |
| Nyanza Province | 0.720919 |
| respiratory diseases | 0.816961 |
| ceramic cookstove | 0.725607 |
| new stoves | 0.824955 |
| measurable health benefits | 0.816652 |
| upesi jiko | 0.726744 |
| role—and novel marketing | 0.823456 |
| Global Alliance | 0.832611 |
| relatively new sector | 0.792658 |
| pm ET | 0.724319 |
| KENYA BLOG | 0.773756 |
| impoverished communities | 0.718901 |
| cooking technologies | 0.720075 |
| air pollution | 0.89449 |
| known risk factor | 0.800213 |
| small window cut | 0.809687 |
|
CLICK HERE |
| 8810 |
Centers for Disease Control and Prevention |
Html |
en |
Naegleria fowleri - Images of Naegleria fowleri |
Information for health professionals about Naegleria fowleri. Education and information about the brain eating ameba Naegleria fowleri that causes encephalitis and death including frequently asked questions, biology, sources of infection, diagnosis, treatment, prevention and control, and other publications and pertinent information for the public and medical professionals. |
| large numbers | 0.352042 |
| arrows | 0.310526 |
| section | 0.329492 |
| videos | 0.310923 |
| photos | 0.310137 |
| characteristic nuclear morphology | 0.400604 |
| shipping instructions | 0.364528 |
| large cluster | 0.350598 |
| CDC Emergency Operations | 0.41789 |
| real-time | 0.3108 |
| cerebral portion | 0.414138 |
| wet mount | 0.357582 |
| contact | 0.311015 |
| specimen collection guidance | 0.416747 |
| magnification | 0.43167 |
| phase contrast microscopy | 0.40793 |
| lymphocytes | 0.316101 |
| Higher magnification | 0.396906 |
| Extensive hemorrhage | 0.414053 |
| eosin | 0.318795 |
| Focal hemorrhage | 0.419633 |
| viewers | 0.310654 |
| laboratory diagnosis | 0.419395 |
| photographs | 0.310917 |
| Naegleria fowleri trophozoites | 0.96664 |
|
| exciter filter | 0.355814 |
| large clusters | 0.354855 |
| 24/7 | 0.311057 |
| increased speed | 0.359511 |
| primary amebic meningoencephalitis | 0.418066 |
| Inset | 0.313369 |
| capillaries | 0.313385 |
| PAM patient | 0.467978 |
| treatment recommendations | 0.362499 |
| microscope | 0.323216 |
| frontal cortex | 0.499044 |
| Clinicians | 0.311632 |
| variety | 0.310119 |
| CSF | 0.338105 |
| cysts | 0.328578 |
| brain tissue architecture | 0.402336 |
| Naegleria fowleri trophozoite | 0.645375 |
| polymorphonuclear leukocytes | 0.362375 |
| Center | 0.310998 |
| fluorescent antibody | 0.358053 |
| nucleus | 0.311602 |
| necrosis | 0.351242 |
| diagnostic assistance | 0.364662 |
| anti-Naegleria fowleri antibody | 0.52538 |
|
CLICK HERE |
| 9669 |
Centers for Disease Control and Prevention |
Html |
en |
Veterinary Safety and Health - Other hazards |
null |
| 2004-100D (DVD) | 0.376194 |
| Publications No. | 0.263463 |
| Español | 0.22413 |
| email address | 0.393602 |
| NIOSH The Effects | 0.610531 |
| different file formats | 0.370311 |
| Health Issues | 0.263229 |
| NIOSH Publication No. | 0.957047 |
| animal owners | 0.278399 |
|
| DHHS | 0.235309 |
| AVMA Emergency contact | 0.457198 |
| Workplace Hazards | 0.332927 |
| NIOSH Exposure | 0.595051 |
| Occupational Hazards | 0.4552 |
| Female Reproductive Health | 0.402502 |
| Workplace Violence Prevention | 0.435498 |
| Research Needs | 0.253523 |
|
CLICK HERE |
| 9962 |
Centers for Disease Control and Prevention |
Html |
en |
TAC Registration Form Submitted - Tribal Support |
CDC/ATSDR Tribal Support is the primary link between CDC, the Agency for Toxic Substance and Disease Registry (ATSDR), and tribal governments. CDC/ATSDR’s tribal support activities focus on fulfilling CDC's supportive role in ensuring that American Indian/Alaska Native (AI/AN) communities receive public health services that keep them safe and healthy. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 10060 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Personal Protective Technology : Key Partners and Stakeholders |
The Mission of the PPT Program is to prevent work-related injury, illness, and death by advancing the state of knowledge and application of personal protective technologies (PPT). |
| technology developers | 0.612875 |
| PPT Programs | 0.725604 |
| research priorities | 0.643272 |
| section | 0.532615 |
| sites | 0.532564 |
| expertise | 0.520077 |
| experience | 0.520055 |
| PPT Program execution | 0.846226 |
| official endorsement | 0.717445 |
| NIOSH research dollars | 0.811226 |
| concern | 0.523249 |
| core competencies augment | 0.723202 |
| research team | 0.628562 |
| in-kind contributions | 0.635827 |
| surveillance activities | 0.612094 |
| safety | 0.521698 |
| inherent knowledge | 0.637908 |
| communication | 0.519939 |
| circumstances | 0.521349 |
| following links | 0.699841 |
| PPE needs | 0.629782 |
| protective strategies | 0.614461 |
| Disclaimer | 0.559452 |
| analysis | 0.519976 |
| key stakeholders | 0.637076 |
|
| NIOSH Program | 0.724514 |
| input | 0.549842 |
| stakeholder groups | 0.642994 |
| programmatic accomplishments | 0.621268 |
| targets | 0.52113 |
| content | 0.532374 |
| ultimate success | 0.619272 |
| key partners | 0.606873 |
| NIOSH policy | 0.747323 |
| PPT Program | 0.976006 |
| partnerships | 0.552263 |
| statement | 0.532311 |
| definition | 0.541177 |
| customers | 0.521814 |
| workers | 0.521682 |
| entire process | 0.609025 |
| capabilities | 0.536541 |
| CDC/NOSH | 0.532526 |
| PPT Program research | 0.836638 |
| PPT Program model | 0.840932 |
| health | 0.521713 |
| Collaborative research | 0.62798 |
| jointly developed program | 0.714378 |
| user communities | 0.617743 |
|
CLICK HERE |
| 11966 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH-Approved N100 Particulate Filtering Facepiece Respirators - Suppliers List |
This page contains a suppliers list of NIOSH-Approved N100 Particulate Filtering Facepiece Respirators. |
| PDF version | 0.711788 |
| facepiece respirator | 0.852905 |
| airborne particles | 0.845824 |
| CDC/NIOSH | 0.553908 |
| N100 | 0.464889 |
| procedure | 0.482707 |
| Disclaimer | 0.5265 |
|
| official endorsement | 0.84325 |
| content | 0.496522 |
| NIOSH policy | 0.955076 |
| oil | 0.463497 |
| statement | 0.495902 |
| websites | 0.498321 |
| links | 0.457956 |
|
CLICK HERE |
| 13197 |
Centers for Disease Control and Prevention |
Html |
en |
Identification and Linkage to Care of HCV-Infected Personsin Five Health Centers - Philadelphia, Pennsylvania,2012-2014 |
Catelyn Coyle, MPH1, Kendra Viner, PhD2, Elizabeth Hughes, DrPH3, Helena Kwakwa, MD2, Jon E. Zibbell, PhD3, Claudia Vellozzi, MD3, Deborah Holtzman, PhD3 (Author affiliations at the end of text). |
| HCV treatment | 0.346868 |
| HCV care continuum | 0.32759 |
| HCV antibody tests | 0.318799 |
| Mary Howard Health | 0.310637 |
| HCV treatment initiation | 0.307191 |
| HCV infection | 0.997509 |
| project | 0.240346 |
| health centers | 0.372435 |
| community-based HCV testing | 0.322468 |
| HCV testing | 0.756843 |
| HCV tests | 0.465969 |
| local HCV providers | 0.30523 |
| on-site HCV treatment | 0.298035 |
| project manager | 0.207558 |
| linkage-to-care coordinator | 0.347846 |
| HCV protocols | 0.272929 |
| reflex HCV testing | 0.344466 |
| confirmatory HCV-RNA test | 0.259577 |
| HCV linkage-to-care protocol | 0.303793 |
| HCV testing protocols | 0.360855 |
|
| public health | 0.200864 |
| assistant-initiated HCV testing | 0.341386 |
| test results | 0.20771 |
| patients | 0.50566 |
| HCV testing protocol | 0.38717 |
| HCV care specialist | 0.398101 |
| Nursing Centers Consortium | 0.201761 |
| HCV disease etiology | 0.327994 |
| community health centers | 0.212488 |
| current HCV infection | 0.609265 |
| HCV-RNA test | 0.371982 |
| health center | 0.374698 |
| public housing residents | 0.206544 |
| Howard Health Center | 0.306154 |
| PHMC Care Clinic | 0.446661 |
| HCV medical appointments | 0.306165 |
| HCV-infected patients | 0.286619 |
| routine HCV testing | 0.499537 |
| HCV testing process | 0.337223 |
| positive HCV-antibody test | 0.206107 |
|
CLICK HERE |